Sodium Sulfacetamide NDC 16477-411

NDC codes

FDA NDC Directory

Product NDC (as listed)16477-411Labeler and product segments. Claims need a package NDC.

Product NDC at billing width16477-0411Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
16477-411-08	16477041108	1 BOTTLE in 1 CARTON (16477-411-08) / 237 mL in 1 BOTTLEMarketed from Sep 13, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Sulfacetamide
Generic name (nonproprietary): sodium sulfacetamide
Active ingredients: Sulfacetamide sodium — 100 mg/mL
Dosage form: Shampoo
Route: Topical
Labeler: Laser Pharmaceuticals, LLC
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Sep 13, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Sulfonamides (Chemical structure)
Identifiers: Product ID 16477-411_390ab477-4120-9fd3-e063-6294a90aa010SPL ID 390ab477-4120-9fd3-e063-6294a90aa010SPL set ID 055a586a-a840-0205-e063-6394a90a44cbRxCUI 832864UNII 4NRT660KJQUPC 0316477411080
Pharmacologic class: Sulfonamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416477041108 followed by a unit qualifier and the quantity

Package 16477-0411-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 3, 2025.

Indications (excerpt from the label)

INDICATIONS: This product is intended for topical application in the following scaling dermatoses: seborrheic dermatitis and seborrhea sicca (dandruff).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)